Key T.J., Appleby P.N., Reeves G.K., Roddam A.W., Helzlsouer K.J., Alberg A.J., Rollison D.E., Overvad K., Kaaks R., Trichopoulos D., Clavel-Chapelon F., Vineis P., Chirlaque M.D., Peeters P.H.M., Rinaldi S., Riboli E., Allen N.E., Allen D.S., Fentiman I.S., Holly J.M., Vatten L.J., Gunnell D., Tretli S., Grønbæk H., Tjønneland A., Krajcik R., Manjer J., Lenner P., Hallmans G., Baglietto L., English D.R., Giles G.G., Severi G., Morris H.A., Hankinson S.E., Schernhammer E.S., Koenig K., Zeleniuch-Jacquotte A., Arslan A.A., Toniolo P., Shore R.E., Krogh V., Micheli A., Berrino F., Muti P., Schairer C., Ziegler R.G., Berg C.D., McCarty C.A., Bueno-de-Mesquita H.B., Cauley J.A., Lui L.Y., Cummings S.R., Gunter M.J., Rohan T.E., Strickler H.D. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: Pooled individual data analysis of 17 prospective studies. The Lancet Oncology. 1 June 2010. 11:530-542. 10.1016/S1470-2045(10)70095-4
AÑO: 2010; IF: 17.764
